{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:29:30Z","timestamp":1793042970492,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004271","name":"Sapienza Universit\u00e0 di Roma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cpcardiol.2022.101215","type":"journal-article","created":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T16:08:02Z","timestamp":1650470882000},"page":"101215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Heart Failure After ST-Elevation Myocardial Infarction: Beyond Left Ventricular Adverse Remodeling"],"prefix":"10.1016","volume":"48","author":[{"given":"Marco Giuseppe","family":"Del Buono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian M.","family":"Garmendia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio M.","family":"Seropian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.","family":"Berrocal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Biondi-Zoccai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory R.","family":"Trankle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bucciarelli-Ducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2022.101215_bib0001","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/eurheartj\/eht529","article-title":"Reperfusion therapy for ST elevation acute myocardial infarction 2010\/2011: current status in 37 ESC countries [published correction appears in Eur Heart J. 2014 Oct 7;35(38):2697]","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J."},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0003","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","article-title":"Post-myocardial infarction heart failure","volume":"6","author":"Bahit","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0004","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0735-1097(01)01711-9","article-title":"The relationships of left ventricular ejection fraction, end-systolic volume index and infarct size to six-month mortality after hospital discharge following myocardial infarction treated by thrombolysis","volume":"39","author":"Burns","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0005","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/01.CIR.101.25.2981","article-title":"Left ventricular remodeling after myocardial infarction: pathophysiology and therapy","volume":"101","author":"Sutton","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11886-017-0876-4","article-title":"Adverse remodeling and reverse remodeling after myocardial infarction","volume":"19","author":"Bhatt","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0007","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ahj.2020.02.017","article-title":"Cardiac remodeling after large ST-elevation myocardial infarction in the current therapeutic era","volume":"223","author":"Daubert","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0008","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.jacc.2016.05.053","article-title":"Bioabsorbable intracoronary matrix for prevention of ventricular remodeling after myocardial infarction","volume":"68","author":"Rao","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0009","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa1505489","article-title":"Cyclosporine before PCI in patients with acute myocardial infarction","volume":"373","author":"Cung","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0010","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1093\/eurheartj\/ehaa651","article-title":"The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial","volume":"41","author":"Mathur","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.119.009937","article-title":"Redefining adverse and reverse left ventricular remodeling by cardiovascular magnetic resonance following ST-segment-elevation myocardial infarction and their implications on long-term prognosis","volume":"13","author":"Bulluck","year":"2020","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0012","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014941","article-title":"Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction","volume":"9","author":"Abbate","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0013","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.jcmg.2019.02.025","article-title":"Prognostic value of initial left ventricular remodeling in patients with reperfused STEMI","volume":"12","author":"Rodriguez-Palomares","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0014","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1161\/CIRCULATIONAHA.121.056177","article-title":"Effect of colchicine on myocardial injury in acute myocardial infarction","volume":"144","author":"Mewton","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0015","article-title":"Inhibition of p38 MAP kinase in patients with st-elevation myocardial infarction - findings from the LATITUDE TIMI 60 Trial","author":"Cavender","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0016","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/01.CIR.0000036014.90197.FA","article-title":"Left ventricular remodeling after primary coronary angioplasty: patterns of left ventricular dilation and long-term prognostic implications","volume":"106","author":"Bolognese","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0017","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/eurheartj\/ehr064","article-title":"Relationship between location and size of myocardial infarction and their reciprocal influences on post-infarction left ventricular remodelling","volume":"32","author":"Masci","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0018","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchf.2019.08.014","article-title":"Left ventricular post-infarct remodeling: implications for systolic function improvement and outcomes in the modern era","volume":"8","author":"van der Bijl","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0019","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1161\/01.CIR.96.10.3294","article-title":"Cardiovascular death and left ventricular remodeling two years after myocardial infarction: baseline predictors and impact of long-term use of captopril: information from the Survival and Ventricular Enlargement (SAVE) trial","volume":"96","author":"St John Sutton","year":"1997","journal-title":"Circulation."},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0735-1097(94)00431-O","article-title":"Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction","volume":"25","author":"Chareonthaitawee","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0021","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","article-title":"Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials","volume":"67","author":"Stone","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0022","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/CIRCULATIONAHA.105.570648","article-title":"Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease [published correction appears in Circulation. 2006 Aug 22;114(8):e365]","volume":"113","author":"Kwong","year":"2006","journal-title":"Circulation."},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0023","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.009879","article-title":"Time delay, infarct size, and microvascular obstruction after primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction","volume":"14","author":"Redfors","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0024","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0002-9149(78)90869-X","article-title":"Infarct expansion vs extension: two different complications of acute myocardial infarction","volume":"41","author":"Hutchins","year":"1978","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1161\/01.CIR.74.4.693","article-title":"Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion","volume":"74","author":"McKay","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0026","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/CIRCRESAHA.119.315344","article-title":"Optimized treatment of ST-elevation myocardial infarction","volume":"125","author":"Niccoli","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0027","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"78","author":"Del Buono","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0028","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2021.10.034","article-title":"Intramyocardial hemorrhage and the \"wave front\" of reperfusion injury compromising myocardial salvage","volume":"79","author":"Liu","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0029","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/0735-1097(92)90314-D","article-title":"Left ventricular remodeling in the year after first anterior myocardial infarction: a quantitative analysis of contractile segment lengths and ventricular shape","volume":"19","author":"Mitchell","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0030","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0735-1097(00)00601-X","article-title":"Remote myocardial dysfunction after acute anterior myocardial infarction: impact of left ventricular shape on regional function: a magnetic resonance myocardial tagging study","volume":"35","author":"Bogaert","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0031","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0167-5273(97)00070-3","article-title":"Opposite effects of the remodeling of infarcted and non-infarcted myocardium on left ventricular function early after infarction in humans. An echocardiographic study in patients examined before and after myocardial infarction","volume":"60","author":"Golia","year":"1997","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0032","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","article-title":"Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction","volume":"67","author":"Westman","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0033","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0034","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.jacc.2016.01.073","article-title":"Inflammation as a driver of adverse left ventricular remodeling after acute myocardial infarction","volume":"67","author":"Westman","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0035","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/01.CIR.97.22.2202","article-title":"Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group","volume":"97","year":"1998","journal-title":"Circulation."},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0036","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(00)02212-1","article-title":"Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group","volume":"355","author":"Flather","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0037","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition vs enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.cpcardiol.2022.101215_bib0038","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1016\/j.jacc.2018.07.102","article-title":"Sacubitril\/valsartan averts adverse post-infarction ventricular remodeling and preserves systolic function in rabbits","volume":"72","author":"Torrado","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0039","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa2104508","article-title":"PARADISE-MI investigators and committees. angiotensin receptor-neprilysin inhibition in acute myocardial infarction","volume":"385","author":"Pfeffer","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0040","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1161\/01.CIR.0000068340.96506.0F","volume":"107","author":"Hayashi","year":"2003","journal-title":"Circulation."},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0041","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011119003788","article-title":"The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study","volume":"15","author":"Pitt","year":"2001","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0042","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/eurjhf\/hfp136","article-title":"Timing of eplerenone initiation and outcomes in patients with heart failure after acute myocardial infarction complicated by left ventricular systolic dysfunction: insights from the EPHESUS trial","volume":"11","author":"Adamopoulos","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0043","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/01.CIR.0000108928.25690.94","article-title":"Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy","volume":"109","author":"Doughty","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0044","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0735-1097(97)00527-5","article-title":"Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size","volume":"31","author":"Hu","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0045","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1016\/j.jacc.2017.03.578","article-title":"\u03b2-Blockers and mortality after acute myocardial infarction in patients without heart failure or ventricular dysfunction","volume":"69","author":"Dondo","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0046","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/eurheartj\/ehr311","article-title":"Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy","volume":"32","author":"Tardif","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0047","first-page":"270","article-title":"Safety of intravenous ivabradine in acute ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a randomized, placebo-controlled, double-blind, pilot study","volume":"2","author":"Steg","year":"2013","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0048","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0049","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0050","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.amjcard.2014.11.003","article-title":"Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies)","volume":"115","author":"Abbate","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0051","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0052","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0053","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.cpcardiol.2022.101215_bib0054","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jacc.2021.04.105","article-title":"Clarification regarding the lack of heart failure events in the ASSAIL-MI trial","volume":"78","author":"Del Buono","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0055","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/1403494819829333","article-title":"Ischemic heart failure as a complication of incident acute myocardial infarction: Timing and time trends: A national analysis including 78,814 Danish patients during 2000-2009","volume":"48","author":"Sulo","year":"2020","journal-title":"Scand J Public Health"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0056","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/ehjcvp\/pvab075","article-title":"Interleukin-1 blockade with anakinra and heart failure following st-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials","volume":"8","author":"Abbate","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0057","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.jacc.2019.01.072","article-title":"Exercise intolerance in patients with heart failure: JACC state-of-the-art review","volume":"73","author":"Del Buono","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0058","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.pcad.2020.04.011","article-title":"Heart failure with preserved ejection fraction diagnosis and treatment: An updated review of the evidence","volume":"63","author":"Del Buono","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0059","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jacc.2018.04.039","article-title":"Myocardial injury and cardiac reserve in patients with heart failure and preserved ejection fraction","volume":"72","author":"Obokata","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0060","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41598-022-05374-w","article-title":"Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction","volume":"12","author":"Del Buono","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0061","article-title":"Effect of IL-1 blockade with anakinra on heart failure outcomes in patients with anterior vs non-anterior STEMI [published online ahead of print, 2022 Feb 11]","author":"Del Buono","year":"2022","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0062","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/clc.22378","article-title":"Left ventricular diastolic dysfunction and E\/E' ratio as the strongest echocardiographic predictors of reduced exercise capacity after acute myocardial infarction","volume":"38","author":"Fontes-Carvalho","year":"2015","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0063","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/ejhf.37","article-title":"Cardiorespiratory fitness and risk of heart failure: a population-based follow-up study","volume":"16","author":"Khan","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0064","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14779072.2020.1806057","article-title":"Cardiopulmonary exercise testing - refining the clinical perspective by combining assessments","volume":"18","author":"Arena","year":"2020","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.cpcardiol.2022.101215_bib0065","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCOUTCOMES.112.966150","article-title":"Defining heart failure end points in ST-segment elevation myocardial infarction trials: integrating past experiences to chart a path forward","volume":"5","author":"Eapen","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622001128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280622001128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:41:09Z","timestamp":1758940869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280622001128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":65,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0146280622001128"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101215","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart Failure After ST-Elevation Myocardial Infarction: Beyond Left Ventricular Adverse Remodeling","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"101215"}}